JAK1 and neoplasm: Oxymatrine (OMT), the oxide derivative of MT, inhibited tumor growth in a lung cancer xenograft model by blocking JAK1, JAK2 and Src kinase activation upstream of STAT5, thereby suppressing STAT5 phosphorylation [208].